Ticker
INMBCompany Name
INMUNE BIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 37.68M | $ 0 | 0% |
3/31/2025 | $ 37.8M | $ 16.51M | 43.69% |
12/31/2024 | $ 39.56M | $ 16.51M | 41.74% |
9/30/2024 | $ 52.78M | $ 16.51M | 31.29% |
6/30/2024 | $ 52.45M | $ 16.51M | 31.48% |
3/31/2024 | $ 46.83M | $ 16.51M | 35.26% |
12/31/2023 | $ 57M | $ 16.51M | 28.97% |
9/30/2023 | $ 62.7M | $ 16.51M | 26.34% |
6/30/2023 | $ 69.72M | $ 16.51M | 23.69% |
3/31/2023 | $ 73.98M | $ 16.51M | 22.32% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for INMUNE BIO INC is calculated as follows: Intangibles [ $ 16.51M ] / Assets [ $ 42.82M ]
(=) Intang. to Assets [ 38.57% ]
Minimum
Jun 30, 2025
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.23K |
---|---|
min | 0% |
max | 23.21% |
average | 3.99% |
median | 0.52% |
std | 6.09% |